This bill introduces a new subsection to section 43-15.3-08 of the North Dakota Century Code, which outlines prohibited actions for drug manufacturers regarding their interactions with contract pharmacies and covered entities. It defines key terms such as "contract pharmacy," "covered entity," and "drug" in relation to federal drug discount programs. The bill establishes that it is a class B misdemeanor for manufacturers or their affiliates to engage in practices that deny or restrict the acquisition of drugs by contract pharmacies on behalf of covered entities, prohibit dispensing of drugs, or require unnecessary data submissions as a condition for drug access.

Additionally, the bill prohibits manufacturers from interfering with the dispensing of drugs to eligible patients and restricts the offering of rebates unless they are in the form of discounts at the time of sale and comply with federal law. However, it clarifies that these provisions do not apply to the limited distribution of drugs as mandated by federal regulations. Overall, the legislation aims to protect the rights of covered entities and contract pharmacies in accessing necessary medications.